RecruitingPhase 1NCT06327685
Avapritinib With Decitabine in Patients With SM-AHN
Studying Mastocytosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Principal Investigator
- Andrew Kuykendall, MDMoffitt Cancer Center
- Intervention
- Avapritinib(drug)
- Enrollment
- 34 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2027
Study locations (7)
- Mayo Clinic - Arizona, Phoenix, Arizona, United States
- Stanford University Medical Center, Palo Alto, California, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- University of Utah Health, Salt Lake City, Utah, United States
Collaborators
Blueprint Medicines Corporation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06327685 on ClinicalTrials.govOther trials for Mastocytosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07328178Analysis of the Role of IgE Proteoforms in Health and DiseaseKU Leuven
- RECRUITINGPHASE4NCT06748001Avapritinib Rollover StudyBlueprint Medicines Corporation
- RECRUITINGNCT06466889Mastocytosis Registry (of Zurich)University of Zurich
- ACTIVE NOT RECRUITINGNCT06065007Quality of Life and Disease-related Symptoms in Individuals With Systemic MastocytosisUppsala University
- RECRUITINGNCT06440148Relationship Between Circulating Sclerostin and Bone Lesions in Patients With MastocytosisMedical University of Lublin
- RECRUITINGNCT00044122Study of Factors Regulating Mast Cell ProliferationNational Institute of Allergy and Infectious Diseases (NIAID)